12 August 2020
From domestic market, the JCI still has room for limited gain while testing the 5,200 level. Investors will monitor the progress of vaccine news such as the clinical trial scheduled to start in Bandung and news about Russia registering the first Covid-19 vaccine without going through phase 3.





